Administration of non-glycosylated, recombinant human IL.sub.2 i

Details Administration of non-glycosylated, recombinant human IL.sub.2 i Administration of non-glycosylated, recombinant human IL.sub.2 i

1995-10-17

1999-02-23

Walsh, Stephen

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

514 2, 530351, A61K 3820

Patent

active

058740767

ABSTRACT:
A biologically active, non-glycosylated recombinant human Interleukin 2 (R-hIL.sub.2) in reduced form, process for its preparation and method of use.

REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4569790 (1986-02-01), Koths et al.
patent: 4604377 (1986-08-01), Fernandes et al.
patent: 4654830 (1987-03-01), Yasushi et al.
patent: 4690915 (1987-09-01), Rosenberg
patent: 5614185 (1997-03-01), Koths et al.
patent: 5643566 (1997-07-01), Hanisch et al.
Weir et al.. (Biochem J. 245: 85-92, 1987).
Robb et al.. (PNAS 80: 5990-94, 1983).
Yamada et al. 1987, (Arch. Biochem Biophys 257, 194).

Affiliated with

Also associated with

Rating

Administration of non-glycosylated, recombinant human IL.sub.2 i does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of non-glycosylated, recombinant human IL.sub.2 i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of non-glycosylated, recombinant human IL.sub.2 i will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-304132